Namodenoson

DB12885InvestigationalSmall molecule

Namodenoson has been used in trials studying the treatment of Chronic Hepatitis C and Hepatocellular Carcinoma.

Chemical structure of Namodenoson
Mechanism
Curator reviewed
Formula / weight
C18H18ClIN6O4 · 544.73 g/mol (avg)
Also known as
2-Chloro-N(6)-(3-iodobenzyl)adenosine-5'-N-methyluronamide
Code names
CF-102 · Cl-IB-MECA

Resolves to

Compound
UNIIZ07JR07J6CCAS163042-96-4ChEMBLCHEMBL431733PubChem3035850
Structure
InChIKeyIPSYPUKKXMNCNQ-PFHKOEEOSA-NSMILESCNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(NCC3=CC=CC(I)=C3)N=C(Cl)N=C12
Targets
P0DMS8ADORA3

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
7Clinical trialsPhase, status and sponsor resolved per trial
Sign in
7+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Namodenoson, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In